Newsletter
The FDA’s Pressure-Packed Alzheimer’s Drug Decision

Archive-Tradeoffs

The FDA’s Pressure-Packed Alzheimer’s Drug Decision

The U.S. Food and Drug Administration faces a costly and consequential decision over whether to approve a controversial new Alzheimer’s drug.
June 3, 2021

The FDA’s Pressure-Packed Alzheimer’s Drug Decision

The U.S. Food and Drug Administration faces a costly and consequential decision over whether to approve a controversial new Alzheimer’s drug.

Guest:

Caleb Alexander, Professor of Epidemiology and Medicine, Johns Hopkins Bloomberg School of Public Health

View the transcript for today’s episode: https://tradeoffs.org/2021/06/03/the-fdas-pressure-packed-alzheimers-drug-decision

Take our short listener survey, and you could win a $50 gift card! bit.ly/TradeoffsSurvey

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod


See acast.com/privacy for privacy and opt-out information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp